AZ 960 is primarily utilized in the field of cancer research due to its role as a potent and selective inhibitor of the JAK2 kinase. This enzyme is often implicated in various types of cancers, particularly myeloproliferative disorders. Researchers employ AZ 960 to study the pathways and mechanisms that drive tumor growth and survival, providing insights that could lead to the development of targeted cancer therapies. Additionally, it is used in preclinical studies to evaluate its efficacy in inhibiting cancer cell proliferation and inducing apoptosis, making it a valuable tool in the exploration of new treatment strategies for malignancies associated with JAK2 signaling dysregulation.